Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study
Ann Oncol. 2025 May 16:S0923-7534(25)00200-5. doi: 10.1016/j.annonc.2025.05.008.…
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
Ann Oncol. 2025 Apr 8:S0923-7534(25)00135-8. doi: 10.1016/j.annonc.2025.04.001.…
Unraveling the power of NAP-CNB’s machine learning-enhanced tumor neoantigen prediction
Elife. 2025 Mar 11;13:RP95010. doi: 10.7554/eLife.95010.ABSTRACTIn…
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer
Nat Commun. 2025 Mar 10;16(1):2374. doi: 10.1038/s41467-025-57470-w.ABSTRACTUveal…
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial
Clin Cancer Res. 2025 Feb 17;31(4):659-666. doi: 10.1158/1078-0432.CCR-24-2636.ABSTRACTPURPOSE:…
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis
Mol Ther Oncol. 2024 Dec 21;33(1):200928. doi: 10.1016/j.omton.2024.200928.…
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
Lancet. 2024 Sep 13:S0140-6736(24)01653-2. doi: 10.1016/S0140-6736(24)01653-2.…
Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy
Mol Ther Oncol. 2024 Aug 23;32(3):200863. doi: 10.1016/j.omton.2024.200863.…
Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma
Cancers (Basel). 2024 Sep 1;16(17):3053. doi: 10.3390/cancers16173053.ABSTRACTUveal…
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study
Future Oncol. 2024 Aug 12:1-9. doi: 10.1080/14796694.2024.2385287.…
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Eur Urol Oncol. 2024 Jun 25:S2588-9311(24)00145-7. doi: 10.1016/j.euo.2024.05.013.…
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma
Nat Commun. 2024 Jun 24;15(1):5352. doi: 10.1038/s41467-024-49718-8.ABSTRACTImmune…
